The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT).
about
Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell CarcinomaStereotactic body radiotherapy for the treatment of medically inoperable primary renal cell carcinoma: Current evidence and future directionsMetastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalitiesQuantification of renal function following stereotactic body radiotherapy for pancreatic cancer: secondary dosimetric analysis of a prospective clinical trial.Novel application of stereotactic ablative radiotherapy using CyberKnife(®) for early-stage renal cell carcinoma in patients with pre-existing chronic kidney disease: Initial clinical experiences.Radical irradiation of extracranial oligometastases.Role of radiation therapy in the management of renal cell cancerRenal cell carcinoma treated with stereotactic radiotherapy with histological change confirmed on autopsy: a case report.Short communication: timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial (99m)Tc-DMSA SPECT/CT.Role of radiation therapy for renal tumors.Clinical outcome of high-dose bolus intravenous interleukin-2 with a modified administration schedule for Asian patients with metastatic renal cell carcinoma.Image-guided stereotactic body radiation therapy (SBRT): an emerging treatment paradigm with a new promise in radiation oncology.Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group "Stereotactic Radiotherapy".The Efficacy of Conventionally Fractionated Radiation in the Management of Osseous Metastases from Metastatic Renal Cell Carcinoma.
P2860
Q26774094-BFA5372A-6AD9-40E8-8B69-D59214F49293Q26796394-60B648E3-97F4-4EC8-AB2E-226BE891DCCDQ26852437-9CF43B81-3E36-4DEB-B6E6-A8540647815FQ33612704-42B1C334-7374-40D7-8021-098C63449DC7Q33778271-8B838D6F-824E-48AC-BB1F-D8D60F813CAFQ34124296-9837CD1F-96FB-4056-8394-EDAEFA81A3CEQ34657336-BD758F73-C41B-442C-96E2-AEE16DE224ABQ35157799-0B2F1411-36C8-4CB1-8DED-7C3414F6419AQ35450158-A5EF0FF0-B7B1-4EA6-9160-C853F63EB88FQ37595651-5BA18A5B-917A-4874-9B9B-1ADDC410EC4AQ39067371-1EB22633-D712-4C98-9A01-5CD0D01C2513Q41877200-BEBF11EA-3A9A-4402-9EBD-62A886E75D90Q47103965-8669DFFB-DBC5-42FC-9CD8-08E3C8A5405FQ54962836-96E767CD-FD44-47E9-8573-90013841189F
P2860
The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT).
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The treatment of primary and m ...... body radiation therapy (SBRT).
@en
The treatment of primary and metastatic renal cell carcinoma
@nl
type
label
The treatment of primary and m ...... body radiation therapy (SBRT).
@en
The treatment of primary and metastatic renal cell carcinoma
@nl
prefLabel
The treatment of primary and m ...... body radiation therapy (SBRT).
@en
The treatment of primary and metastatic renal cell carcinoma
@nl
P2093
P2860
P356
P1476
The treatment of primary and m ...... body radiation therapy (SBRT).
@en
P2093
Ac Paulino
M Galli-Guevara
M Gonzalez
P2860
P356
10.2349/BIIJ.3.1.E6
P407
P577
2007-01-01T00:00:00Z